Using Simulation to Address Capacity Limitations.
| Publicado en: | Pharmaceutical Technology Europe Vol. 29; no. 9; pp. 36 - 40 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125113390&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 125113390 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Sep2017 vid: 29 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 125113390 125113390 ppf: 36 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Using Simulation to Address Capacity Limitations. aug: au: Robinson, John Miller, Spencer Baxter, Laurence T. Hunt, Stephen Todd, Bob Pekny, Joseph F. affil: Principal engineer, KBI Biopharma sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|